DEXCOM, INC. Investment Income, Interest and Dividend
DEXCOM, INC. (DXCM) reported Investment Income, Interest and Dividend of $16.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2026-07-30
- DEXCOM, INC. investment income, interest and dividend for the quarter ending 2026-06-30 was $16.90M, a 39.64% decline year-over-year.
- DEXCOM, INC. investment income, interest and dividend for the quarter ending 2026-03-31 was $19.50M, a 31.58% decline year-over-year.
- DEXCOM, INC. investment income, interest and dividend for the quarter ending 2025-12-31 was $23.50M, a 20.88% decline year-over-year.
- DEXCOM, INC. investment income, interest and dividend for the quarter ending 2025-09-30 was $32.70M, a 2.19% increase year-over-year.
- DEXCOM, INC. investment income, interest and dividend for fiscal 2025 was $112.70M, a 16.02% decline from fiscal 2024.
- DEXCOM, INC. investment income, interest and dividend for fiscal 2024 was $134.20M, a 0.59% decline from fiscal 2023.
- DEXCOM, INC. investment income, interest and dividend for fiscal 2023 was $135.00M, a 467.23% increase from fiscal 2022.
- DEXCOM, INC. investment income, interest and dividend for fiscal 2022 was $23.80M, a 1300.00% increase from fiscal 2021.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 9 month | Investment Income, Interest and Dividend 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.90M 10-Q · filed 2026-07-30 | $36.40M 10-Q · filed 2026-07-30 | $59.90M derived: sum of 3 quarters · filed 2026-07-30 | $92.60M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $19.50M 10-Q · filed 2026-04-30 | $43.00M derived: sum of 2 quarters · filed 2026-04-30 | $75.70M derived: sum of 3 quarters · filed 2026-04-30 | $103.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $23.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $56.20M derived: sum of 2 quarters · filed 2026-02-12 | $84.20M derived: sum of 3 quarters · filed 2026-07-30 | $112.70M 10-K · filed 2026-02-12 |
| 2025-09-30 | $32.70M 10-Q · filed 2025-10-30 | $60.70M derived: sum of 2 quarters · filed 2026-07-30 | $89.20M 10-Q · filed 2025-10-30 | $118.90M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $28.00M 10-Q · filed 2026-07-30 | $56.50M 10-Q · filed 2026-07-30 | $86.20M derived: sum of 3 quarters · filed 2026-07-30 | $118.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $28.50M 10-Q · filed 2026-04-30 | $58.20M derived: sum of 2 quarters · filed 2026-04-30 | $90.20M derived: sum of 3 quarters · filed 2026-04-30 | $126.40M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $29.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $61.70M derived: sum of 2 quarters · filed 2026-02-12 | $97.90M derived: sum of 3 quarters · filed 2026-02-12 | $134.20M 10-K · filed 2026-02-12 |
| 2024-09-30 | $32.00M 10-Q · filed 2025-10-30 | $68.20M derived: sum of 2 quarters · filed 2025-10-30 | $104.50M 10-Q · filed 2025-10-30 | $138.30M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $36.20M 10-Q · filed 2025-07-30 | $72.50M 10-Q · filed 2025-07-30 | $106.30M derived: sum of 3 quarters · filed 2026-02-12 | $147.80M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $36.30M 10-Q · filed 2025-05-01 | $70.10M derived: sum of 2 quarters · filed 2026-02-12 | $111.60M derived: sum of 3 quarters · filed 2026-02-12 | $149.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $33.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $75.30M derived: sum of 2 quarters · filed 2026-02-12 | $112.70M derived: sum of 3 quarters · filed 2026-02-12 | $135.00M 10-K · filed 2026-02-12 |
| 2023-09-30 | $41.50M 10-Q · filed 2024-10-24 | $78.90M derived: sum of 2 quarters · filed 2024-10-24 | $101.20M 10-Q · filed 2024-10-24 | $114.60M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $37.40M 10-Q · filed 2024-07-25 | $59.70M 10-Q · filed 2024-07-25 | $73.10M derived: sum of 3 quarters · filed 2025-02-18 | $78.80M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $22.30M 10-Q · filed 2024-04-25 | $35.70M derived: sum of 2 quarters · filed 2025-02-18 | $41.40M derived: sum of 3 quarters · filed 2025-02-18 | |
| 2022-12-31 | $13.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $19.10M derived: sum of 2 quarters · filed 2025-02-18 | $23.80M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $5.70M 10-Q · filed 2023-10-26 | $10.40M 10-Q · filed 2023-10-26 | ||
| 2021-12-31 | $1.70M 10-K · filed 2024-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |